These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37182687)

  • 1. Association between methylation in the promoter region of the GAD2 gene and opioid use disorder.
    Tang H; Zhang Y; Xun Y; Yu J; Lu Y; Zhang R; Dang W; Zhu F; Zhang J
    Brain Res; 2023 Aug; 1812():148407. PubMed ID: 37182687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation in the promoter region of the ADRA1A gene is associated with opioid use disorder in Han Chinese.
    Zhang J; Fu X; Lu Y; Cheng C; Wang K; Zhu Y; Xie Q
    Brain Res; 2022 Oct; 1793():148050. PubMed ID: 35964682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic signature of panic disorder: a role of glutamate decarboxylase 1 (GAD1) DNA hypomethylation?
    Domschke K; Tidow N; Schrempf M; Schwarte K; Klauke B; Reif A; Kersting A; Arolt V; Zwanzger P; Deckert J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():189-96. PubMed ID: 23906988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter.
    Sandoval-Sierra JV; Salgado García FI; Brooks JH; Derefinko KJ; Mozhui K
    Clin Epigenetics; 2020 Jun; 12(1):76. PubMed ID: 32493461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of DNA methylation at the OPRM1 promoter region in men with opioid use disorder.
    Ebrahimi G; Asadikaram G; Akbari H; Nematollahi MH; Abolhassani M; Shahabinejad G; Khodadadnejad L; Hashemi M
    Am J Drug Alcohol Abuse; 2018; 44(2):193-199. PubMed ID: 28121474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid Exposure is Associated with Aberrant DNA Methylation of OPRM1 Promoter Region in a Chinese Han Population.
    Xu J; Wang T; Su Z; Zhou X; Xiang Y; He L; Li C; Yang Z; Zhao X
    Biochem Genet; 2018 Oct; 56(5):451-458. PubMed ID: 29564682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts.
    Chorbov VM; Todorov AA; Lynskey MT; Cicero TJ
    J Opioid Manag; 2011; 7(4):258-64. PubMed ID: 21957825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex.
    Labouesse MA; Dong E; Grayson DR; Guidotti A; Meyer U
    Epigenetics; 2015; 10(12):1143-55. PubMed ID: 26575259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional control of Gad2.
    Pan ZZ
    Transcription; 2012; 3(2):68-72. PubMed ID: 22414751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic and sex differences in opioid use disorder in chronic pain: A real-world study linked with OPRM1 DNA methylation.
    Agulló L; Escorial M; Orutño S; Muriel J; Sandoval J; Margarit C; Peiró AM
    Addict Biol; 2024 Jul; 29(7):e13422. PubMed ID: 38949208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation and expression quantitative trait locus rs6296 in the HTR1B gene is associated with susceptibility to opioid use disorder.
    Li Y; Lu Y; Xie Q; Zeng X; Zhang R; Dang W; Zhu Y; Zhang J
    Psychopharmacology (Berl); 2022 Aug; 239(8):2515-2523. PubMed ID: 35438303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of mouse delta-opioid receptor gene by CpG methylation: involvement of Sp3 and a methyl-CpG-binding protein, MBD2, in transcriptional repression of mouse delta-opioid receptor gene in Neuro2A cells.
    Wang G; Wei LN; Loh HH
    J Biol Chem; 2003 Oct; 278(42):40550-6. PubMed ID: 12890683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Promoter Methylation of Gene ERCC3 and Benzene Hematotoxicity.
    Zheng M; Lin F; Hou F; Li G; Zhu C; Xu P; Xing C; Wang Q
    Int J Environ Res Public Health; 2017 Aug; 14(8):. PubMed ID: 28813025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status of CpG sites in the NOTCH4 promoter region regulates NOTCH4 expression in patients with tetralogy of Fallot.
    Zhu Y; Ye M; Xu H; Gu R; Ma X; Chen M; Li X; Sheng W; Huang G
    Mol Med Rep; 2020 Nov; 22(5):4412-4422. PubMed ID: 33000281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain.
    Doehring A; Oertel BG; Sittl R; Lötsch J
    Pain; 2013 Jan; 154(1):15-23. PubMed ID: 23273101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of follistatin (FST) promoter methylation in peripheral blood of patients with polycystic ovary syndrome.
    Sang Q; Zhang S; Zou S; Wang H; Feng R; Li Q; Jin L; He L; Xing Q; Wang L
    Reprod Biomed Online; 2013 Feb; 26(2):157-63. PubMed ID: 23265961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on methylation of two CpG islands of MAOA gene promoter among opium-addicted males undergoing methadone treatment.
    Omarmeli V; Sharafshah A; Albonaim A; Keshavarz P
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(9):841-850. PubMed ID: 35759647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG promoter methylation status is not a prognostic indicator of gene expression in beryllium challenge.
    Tooker BC; Ozawa K; Newman LS
    J Immunotoxicol; 2016 May; 13(3):417-27. PubMed ID: 26673671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of promoter elements in the human mu-opioid receptor gene and regulation by DNA methylation.
    Andria ML; Simon EJ
    Brain Res Mol Brain Res; 1999 Jun; 70(1):54-65. PubMed ID: 10381543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation signatures: Biomarkers of drug and alcohol abuse.
    Mahna D; Puri S; Sharma S
    Mutat Res Rev Mutat Res; 2018; 777():19-28. PubMed ID: 30115428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.